These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15777080)

  • 1. Advances in toxicogenomics.
    Hayes KR; Bradfield CA
    Chem Res Toxicol; 2005 Mar; 18(3):403-14. PubMed ID: 15777080
    [No Abstract]   [Full Text] [Related]  

  • 2. Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery.
    Fostel JM
    Pharmacogenomics; 2007 May; 8(5):425-30. PubMed ID: 17465705
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicogenomics in drug discovery and development -- making an impact.
    Wills Q; Mitchell C
    Altern Lab Anim; 2009 Sep; 37 Suppl 1():33-7. PubMed ID: 19807202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic-based biomarkers of drug-induced nephrotoxicity.
    Davis JW; Kramer JA
    Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):95-101. PubMed ID: 16863471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicogenomics in drug safety assessment.
    Hewitt P; Walijew A
    Pharmacogenomics; 2008 Apr; 9(4):379-82. PubMed ID: 18384252
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxicogenomics in genetic toxicology and hazard determination: introduction and overview.
    Sarrif A; van Delft JH; van Schooten FJ; Gant TW; Elliott BM; van Ravenzwaay B; van Steeg H; Vrijhof H
    Mutat Res; 2005 Aug; 575(1-2):1-3. PubMed ID: 15924883
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicogenomics in genetic toxicology and hazard determination--concluding remarks.
    Sarrif A; van Delft JH; Gant TW; Kleinjans JC; van Vliet E
    Mutat Res; 2005 Aug; 575(1-2):116-7. PubMed ID: 15924887
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicogenomics in the assessment of immunotoxicity.
    Baken KA; Vandebriel RJ; Pennings JL; Kleinjans JC; van Loveren H
    Methods; 2007 Jan; 41(1):132-41. PubMed ID: 17161310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taking stock of toxicogenomics: mini-monograph offers overview.
    Hood E
    Environ Health Perspect; 2004 Mar; 112(4):A231. PubMed ID: 15040318
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxicogenomics using yeast DNA microarrays.
    Yasokawa D; Iwahashi H
    J Biosci Bioeng; 2010 Nov; 110(5):511-22. PubMed ID: 20624688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarrays demystified.
    Medlin J
    Environ Health Perspect; 2004 Mar; 112(4):A222-3. PubMed ID: 15033604
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of toxicogenomics in drug development.
    Gant TW
    Drug News Perspect; 2003 May; 16(4):217-21. PubMed ID: 12942151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of DNA microarray results in the Toxicogenomics Project (TGP) consortium in Japan.
    Noriyuki N; Igarashi Y; Ono A; Yamada H; Ohno Y; Urushidani T
    J Toxicol Sci; 2012; 37(4):791-801. PubMed ID: 22863858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SimuGen Ltd: reliable, early prediction of drug toxicity with toxicogenomics, human cell culture and computational models.
    Wills Q
    Pharmacogenomics; 2007 Aug; 8(8):1081-4. PubMed ID: 17716240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The introduction of toxicogenomics; potential new markers of hepatotoxicity.
    Heijne WH; Stierum RH; Leeman WR; van Ommen B
    Cancer Biomark; 2005; 1(1):41-57. PubMed ID: 17192031
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA; Yang Y; Waring JF
    Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omic profiling for drug safety assessment: current trends and public-private partnerships.
    Gallagher WM; Tweats D; Koenig J
    Drug Discov Today; 2009 Apr; 14(7-8):337-42. PubMed ID: 19340928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-species comparative toxicogenomics as an aid to safety assessment.
    Mattes WB
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):859-74. PubMed ID: 17125406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicogenomics of A375 human malignant melanoma cells.
    Cheng SL; Huang-Liu R; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ
    Pharmacogenomics; 2007 Aug; 8(8):1017-36. PubMed ID: 17716235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted salmon gene array (SalArray): a toxicogenomic tool for gene expression profiling of interactions between estrogen and aryl hydrocarbon receptor signalling pathways.
    Mortensen AS; Arukwe A
    Chem Res Toxicol; 2007 Mar; 20(3):474-88. PubMed ID: 17291011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.